Yiling Pharmaceutical Ltd
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- No.36 Zhujiang Road, Shijiazhuang, 050035, China (CHN)
- Operations here
- manufacture
- FDA identifiers
- FEI 3011640199 · DUNS 544322244
Recent inspection flagged official action
FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 10 drugs. A supply problem here can ripple to all of them.
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2024-10-11
- VAIDrug Quality Assurance2018-06-15
Drugs this plant is listed as making
10 distinct drugs across 32 products name this site in their FDA label.
- AcyclovirAvet Pharmaceuticals Inc.
- Buspirone hydrochlorideEpic Pharma, Llc
- CelecoxibYiling Pharmaceutical, Inc.
- CiprofolxacinSolco Healthcare US, LLC
- Felodipine Extended-release TabletsYiling Pharmaceutical Inc.
- Memantine HydrochlorideCarlsbad Technology, Inc.
- ParoxetineYiling Pharmaceutical, Inc.
- SimvastatinWestminster Pharmaceuticals, LLC
- ValacyclovirYiling Pharmaceutical, Inc.
- Valacyclovir HydrochlorideYiling Pharmaceutical, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.